67 related articles for article (PubMed ID: 19783960)
1. The effect of gadodiamide on cancer cell lines.
Fujimoto T; Finnegan M
Exp Oncol; 2009 Sep; 31(3):185-7. PubMed ID: 19783960
[TBL] [Abstract][Full Text] [Related]
2. Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.
Edward M; Quinn JA; Mukherjee S; Jensen MB; Jardine AG; Mark PB; Burden AD
J Pathol; 2008 Apr; 214(5):584-93. PubMed ID: 18220317
[TBL] [Abstract][Full Text] [Related]
3. Opposite effects of oxytocin on proliferation of osteosarcoma cell lines.
Petersson M
Regul Pept; 2008 Oct; 150(1-3):50-4. PubMed ID: 18384894
[TBL] [Abstract][Full Text] [Related]
4. Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements.
Zhang HL; Ersoy H; Prince MR
J Magn Reson Imaging; 2006 Mar; 23(3):383-7. PubMed ID: 16463306
[TBL] [Abstract][Full Text] [Related]
5. Effect of human granulocyte macrophage-colony stimulating factor on differentiation and apoptosis of the human osteosarcoma cell line SaOS-2.
Postiglione L; Di Domenico G; Giordano-Lanza G; Ladogana P; Turano M; Castaldo C; Di Meglio F; Cocozza S; Montagnani S
Eur J Histochem; 2003; 47(4):309-16. PubMed ID: 14706926
[TBL] [Abstract][Full Text] [Related]
6. Effect of ethanol on human osteosarcoma cell proliferation, differentiation and mineralization.
Vignesh RC; Sitta Djody S; Jayasudha E; Gopalakrishnan V; Ilangovan R; Balaganesh M; Veni S; Sridhar M; Srinivasan N
Toxicology; 2006 Mar; 220(1):63-70. PubMed ID: 16406255
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
[TBL] [Abstract][Full Text] [Related]
9. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
11. Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines.
Cheng YY; Huang L; Lee KM; Li K; Kumta SM
Pediatr Blood Cancer; 2004 May; 42(5):410-5. PubMed ID: 15049011
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of rat osteosarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitor STI571.
Yoshitani K; Honoki K; Morishita T; Kido A; Miyauchi Y; Mii Y; Takakura Y
In Vivo; 2003; 17(3):255-8. PubMed ID: 12929576
[TBL] [Abstract][Full Text] [Related]
13. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
Mackie PS; Fisher JL; Zhou H; Choong PF
Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy.
Torricelli P; Montanari N; Spina V; Manfrini M; Bertoni F; Saguatti G; Romagnoli R
Radiol Med; 2001 Mar; 101(3):145-51. PubMed ID: 11402952
[TBL] [Abstract][Full Text] [Related]
18. Induction of contact-dependent endothelial apoptosis by osteosarcoma cells suggests a role for endothelial cell apoptosis in blood-borne metastasis.
McEwen A; Emmanuel C; Medbury H; Leick A; Walker DM; Zoellner H
J Pathol; 2003 Nov; 201(3):395-403. PubMed ID: 14595751
[TBL] [Abstract][Full Text] [Related]
19. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.
Ek ET; Dass CR; Contreras KG; Choong PF
J Orthop Res; 2007 Dec; 25(12):1671-80. PubMed ID: 17600821
[TBL] [Abstract][Full Text] [Related]
20. High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
Palmero A; Berger M; Venturi C; Ferrero I; Rustichelli D; Berta L; Frairia R; Madon E; Fagioli F
Oncol Rep; 2006 Jan; 15(1):267-73. PubMed ID: 16328067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
